Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-043137
Filing Date
2021-06-24
Accepted
2021-06-24 18:44:06
Documents
1
Period of Report
2021-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3376
  Complete submission text file 0001209191-21-043137.txt   5040
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 177 E COLORADO BLVD STE 700 PASADENA CA 91105
Business Address
Hassard James (Reporting) CIK: 0001799357 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 211044124